Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
Baricitinib bij juveniele idiopathische artritis: JUVE-BASIS
dec 2023 | Arthritis psoriatica, Artritis, JIA